Cleared Special

K013373 - OMNI C ANALYZER

K013373 is the FDA 510(k) clearance for OMNI C ANALYZER by Roche Diagnostics Corp.. It is a Class 2 Chemistry device (product code CEM) cleared through the Special 510(k) pathway after a 22-day FDA review.

K013373 · Roche Diagnostics Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2001
Decision
22d
Days
Class 2
Risk

K013373 is an FDA 510(k) clearance for the OMNI C ANALYZER. Classified as Electrode, Ion Specific, Potassium (product code CEM), Class II - Special Controls.

Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on November 2, 2001 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1600 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Roche Diagnostics Corp. devices

Submission Details

510(k) Number K013373 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2001
Decision Date November 02, 2001
Days to Decision 22 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
66d faster than avg
Panel avg: 88d · This submission: 22d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CEM Electrode, Ion Specific, Potassium
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1600
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CEM Electrode, Ion Specific, Potassium

All 40
Devices cleared under the same product code (CEM) and FDA review panel - the closest regulatory comparables to K013373.
COBAS 6000 SERIES SYSTEM
K060373 · Roche Diagnostics · Mar 2006
UNICEL DXC 600 AND 800 SYNCHRON SYSTEMS
K042291 · Beckman Coulter, Inc. · Nov 2004
ROCHE DIAGNOSTICS OMNI S ANALYZER
K032311 · Roche Diagnostics Corp. · Oct 2003
DIMENSION CLINICAL CHEMISTRY SYSTEM, MODEL XPAND
K010061 · Dade Behring, Inc. · Mar 2001
ALCYON 300I (WITH ISE MODULE) ANALYZER
K993083 · Abbott Laboratories · Oct 1999
NOVA NA/K/CL/LI MODULE
K922943 · Nova Biomedical Corp. · Oct 1992